shot-button
Subscription Subscription
Home > Entertainment News > Bollywood News > Article > Dilip Kumar to be under observation for two more days

Dilip Kumar to be under observation for two more days

Updated on: 17 September,2013 01:59 PM IST  | 
IANS |

Veteran actor Dilip Kumar, who suffered a heart attack on September 15, is stable, but will be kept under observation for two more days before he gets discharged, a friend of the thespian said on Tuesday

Dilip Kumar to be under observation for two more days

The 90-year-old is currently admitted to the Lilavati Hospital here.


Dilip Kumar
Dilip Kumar


"His condition is as stable as it was yesterday (Monday). He is fine but his dicharge date is not yet confirmed yet. Considering his age and the bypass surgery that he underwent in 1999, the doctors wants to observe him for two more days before they discharge him," Udaya Tara Nayar, a close family friend of the actor, said.


Dilip Kumar was admitted in the intensive care unit (ICU) of the hospital on September 15 night after he felt uneasy.

Earlier, his wife and former actress Saira Bano had told reporters that the thespian had been admitted to hospital following "discomfort". Later, the hospital authorities informed that discomfort was caused due to heart attack.

Born as Mohammed Yusuf Khan in Peshawar, now in Pakistan, the 90-year-old adopted the film name of Dilip Kumar and was active in the Indian film industry for over six decades and worked in some of the best films like 'Madhumati', 'Devdas', 'Ram Aur Shyam' and 'Karma'.

He was honoured with Padma Bhushan in 1991 and the Dadasaheb Phalke Award in 1994. Also, in 1998, he was awarded the 'Nishan-E-Pakistan', Pakistan's highest civilian award
u00a0

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK